Jun 28 |
Moderna RSV vaccine endorsed in EU
|
Jun 28 |
EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)
|
Jun 27 |
Moderna (MRNA) Shares Decline on RSV Vaccine Efficacy Data
|
Jun 27 |
RSV vaccine makers’ shares fall as CDC adjusts shot guidance
|
Jun 27 |
CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK
|
Jun 27 |
2 Stocks Down More Than 30% to Buy Right Now
|
Jun 26 |
How consumer spending, election impact markets: Market Domination
|
Jun 26 |
Moderna, Pfizer, and GSK Stocks Fall After Vote on RSV Shots
|
Jun 26 |
Moderna Dives 11% After RSV Vaccine Proves Less Effective Than Pfizer, GSK Shots
|
Jun 26 |
US Equities Markets Close Higher Wednesday as Markets Review New Home Sales Data
|